RGR. R. Gainullin

R. R. Gainullin

*This is an algorithmically generated author record based on publicly available information.

R. R. Gainullin has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • OBTAINING AND USING PHOSPHOLIPIDS AS A STARTING MATERIAL FOR MANUFACTURING LIPOSOMAL DRUGS

    by Edie Minachetdinovna Plotnikova, Mulanur Makhsutovich Shakurov, Ruslan Rustamovich Gaynullin, Gulnaz Ilgizarovna Rakhmatullina, Farit Khabullovich Kalimullin

    Traditional methods of extracting phospholipids require expensive materials such as sunflower oil, egg yolk and squid and fish roe. The yield of the final product remains low, not exceeding 7-10%. Furthermore, a significant amount of cholesterol is detected as an impurity in the product. To address this issue, the present research was conducted to expand the raw material base and utilize phospholipids as a starting material for creating liposomal drug formulations. To solve this problem, dead bees – an apicultural byproduct with a rich biochemical composition that provides comprehensive therapeutic and prophylactic effects – were used as a source of phospholipids. At the same time, the research demonstrated the effectiveness of using dead bees as a raw material for producing a phospholipid complex, a waste product of honey production. A comparative analysis with existing methods for producing phospholipid complexes revealed that the developed method increases the yield of the target product from the starting material. Furthermore, the research allowed us to refine a phospholipid production scheme that ensures an optimal phospholipid composition with the appropriate component ratio, which will subsequently enable the development of highly effective liposomal systems. The developed method for producing phospholipids offers several advantages: the combination of highly efficient preliminary dehydration of the main raw material of the bee product – dead bees – followed by acetone extraction at specific temperatures allows for a single extraction with simultaneous purification of the phospholipids from polypeptide impurities. At the same time, the conducted research reduced the duration of the extraction process through comprehensive experimental selection of the optimal solvent ratio of CHCl3, C2H6O, and CH3COOH, temperature parameters and stirring speed. Importantly, the use of a nitrogen stream in the proposed method for producing phospholipids contributed to an increase in their technological yield.

  • Open Access

    Study of acute toxicity of a complex antimycotic drug

    by R. R. Musin, I. M. Ganiev, R. R. Gainullin, A. M. Tremasova, I. I. Idiyatov, A. I. Eroshin, E. R. Shakirova

    Conducting preclinical studies is an important stage for the introduction of new pharmacological drugs into clinical practice. A prerequisite for this is to conduct toxicological studies. The article presents the results of studying the parameters of acute toxicity of the new antimycotic drug "Fungicor". The experiments were conducted on laboratory nonlinear white rats and mice. The acute toxicity of the drug was studied with intragastric, subcutaneous and subcutaneous administration. It was found that the dose range of the drug from 4000 to 10000 mg / kg body weight for mice and from 4000 to 12000 mg / kg body weight for rats with intragastric administration did not lead to the death of laboratory animals. The vital signs were within the physiological norm and did not differ from the values of the control animals. The maximum tolerated dose (MTD) of "Fungicor" for mice and rats was 10,000 mg/kg and 12,000 mg/kg body weight, respectively. Subcutaneous administration in doses from 4000 to 8000 mg / kg body weight for mice and from 4000 to 10000 mg / kg body weight for rats also did not reveal a negative effect of the drug on the general condition of experimental animals. The maximum tolerated dose was 8000 mg/ kg and 10000 mg/kg, respectively. When studying the cutaneous toxicity of the drug in doses from 1500 to 15000 mg / kg of body weight, the death of experimental mice and rats was not noted. In connection with the above, it can be concluded that the drug "Fungicor" according to GOST 12.1.007-76 belongs to hazard class IV (low-risk substances).

  • Studying the therapeutic effectiveness of an immunoliposomal drug on fatally irradiated rabbits

    by Radiation Federal Center For Toxicological, Ruslan R. Gainullin, Edie M. Plotnikova, Mulanur M. Shakurov, Ramzi N. Nizamov

  • Open Access

    Determination of the antigenic properties of quinoidr adiotoxin using the indirect hemagglutination test (IHA)

    by Z. R. Kamalova, R. R. Gainullin, R. N. Nizamov, Ya. M. Kurbangaleev, M. M. Shakurov

    Relevance. The article presents the results of experiments to determine the antigenic properties (the ability of quinoid radiotoxin to synthesize antiradiotoxic antibodies) of plant radiotoxin using IHA.Methods. An antigenic variant of the erythrocyte diagnosticum (AGED), which is a ram erythrocytes sensitized by radiation antigens, was used to conduct the IHA-test. As control (positive) antiradiation antibodies in the reaction, we used antiradiation antibodies obtained by hyperimmunization of rabbits with a radiation antigen — radiotoxin isolated from the liver tissue of lethally irradiated sheep, tested antitoxic antibodies — hyperimmune sera from sheep hyperimmunized with quinoid (plant) radiotoxin, negative serum obtained from intact (non-irradiated, not vaccinated with any vaccines) sheep, heterologous sera (antiburn, anticolibacillary). The reaction was placed on microplates in a volume of 50 ml and was taken into account according to a four-point system in crosses.Results. The study of the antigenic activity of the test radiation antigen — plant quinoidr adiotoxin (QRT) — using the IHA-test showed that the test antigen has a high antigenic activity, inducing in the body of immunized animals (sheep) the synthesis of antiradiotoxic antibodies, the titers of which significantly exceed those immunized with liver (animal) antigen — animal radiotoxin. Quinoidr adiotoxin, obtained from plant tissue (potato tubers) and conjugated with a protein-lipoid group (incomplete Freund's adjuvant — IFA), has a high antigenicity, inducing the synthesis of specific antiradiotoxic antibodies, which can be used as an essential component of the immunochemical test system — sensitin used for sensitization of micro- and nanoparticles of bentonite in the design of antiradiation antibody variant of bentonited iagnosticum (ABBD).